Biocon LimitedNSE: BIOCON

Press Release Oct 04 2021

· Issued by Biocon Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-oct-04-2021-10

Biocon Limited has informed the Exchange regarding a press release dated October 04, 2021, titled "Biocon expands its Generic Formulations portfolio with the launch of Everolimus tablets in the US.".

View Attachment

6ix hasn’t read this filing yet.

Biocon Limited on 6ix

Earlier from Biocon

Later from Biocon

All Biocon news releases